4.59
price down icon21.54%   -1.26
after-market アフターアワーズ: 4.64 0.05 +1.09%
loading
前日終値:
$5.85
開ける:
$4.52
24時間の取引高:
205.40K
Relative Volume:
0.31
時価総額:
$3.23M
収益:
-
当期純損益:
$-9.60M
株価収益率:
-1.4525
EPS:
-3.16
ネットキャッシュフロー:
$-8.96M
1週間 パフォーマンス:
-20.45%
1か月 パフォーマンス:
-50.38%
6か月 パフォーマンス:
-12.57%
1年 パフォーマンス:
-31.71%
1日の値動き範囲:
Value
$4.42
$4.8867
1週間の範囲:
Value
$4.42
$5.99
52週間の値動き範囲:
Value
$4.20
$28.60

Artelo Biosciences Inc Stock (ARTL) Company Profile

Name
名前
Artelo Biosciences Inc
Name
セクター
Healthcare (1147)
Name
電話
858-925-7049
Name
住所
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Name
職員
6
Name
Twitter
@ArteloBio
Name
次回の収益日
2024-12-11
Name
最新のSEC提出書
Name
ARTL's Discussions on Twitter

ARTL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARTL
Artelo Biosciences Inc
4.59 11.48M 0 -9.60M -8.96M -3.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-08 アップグレード D. Boral Capital Hold → Buy
2021-02-12 開始されました Ladenburg Thalmann Buy

Artelo Biosciences Inc (ARTL) 最新ニュース

pulisher
Sep 30, 2025

Is Artelo Biosciences Inc. stock a top momentum playWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewswire

Sep 30, 2025
pulisher
Sep 30, 2025

Artelo Biosciences prices $2 million public offering of common stock By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

$2 Million Capital Raise: Artelo Biosciences Prices Public Offering for Cancer Drug Development - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Form 424B5 ARTELO BIOSCIENCES, INC. - StreetInsider

Sep 30, 2025
pulisher
Sep 30, 2025

Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 30, 2025
pulisher
Sep 30, 2025

How Artelo Biosciences Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Candlestick signals on Artelo Biosciences Inc. stock todayMarket Trend Summary & Growth Focused Entry Reports - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

When is the best time to exit Artelo Biosciences Inc.Day Trade & Community Consensus Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Artelo Biosciences launches underwritten public offering of stock - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Nasdaq-Listed Biotech Artelo Biosciences Announces New Public Stock Offering for Cancer Research - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

Can Artelo Biosciences Inc. stock surprise with earnings upsideWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Statistical indicators supporting Artelo Biosciences Inc.’s strengthJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Artelo Biosciences Inc. stock a defensive play in 2025Portfolio Profit Report & Weekly Hot Stock Watchlists - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How to track smart money flows in Artelo Biosciences Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences (ARTL) Shares Promising Interim Data from Pha - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Presentation of Positive - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

6% Weight Gain: Artelo's Cancer Cachexia Drug Shows Promising Results in Phase 2 Trial with Activity Boost - Stock Titan

Sep 29, 2025
pulisher
Sep 27, 2025

Visual trend scoring systems applied to Artelo Biosciences Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Is Artelo Biosciences Inc. stock a safe haven assetEarnings Risk Summary & Growth Focused Stock Reports - newser.com

Sep 27, 2025
pulisher
Sep 22, 2025

How to integrate Artelo Biosciences Inc. into portfolio analysis toolsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Aug PreEarnings: What is Artelo Biosciences Incs TAM Total Addressable MarketQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Can Artelo Biosciences Inc. continue delivering strong returnsPortfolio Risk Report & Verified High Yield Trade Plans - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Macro Review: Is Artelo Biosciences Inc impacted by rising ratesPortfolio Gains Summary & Daily Market Momentum Tracking - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Real time breakdown of Artelo Biosciences Inc. stock performance2025 Market Sentiment & Daily Stock Trend Reports - newser.com

Sep 19, 2025

Artelo Biosciences Inc (ARTL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):